IMV Inc.

  • Home
  • About Us
    • Overview
    • Management Team
    • Board of Directors
    • Scientific & Clinical Advisors
  • Careers
    • Overview
    • Life at IMV
  • The DPX™ Platform
    • Overview
    • Scientific Publications & Posters
  • Clinical Pipeline
    • Overview
    • Maveropepimut-S
    • DPX-RSV
    • DPX-COVID-19
    • Clinical Trials
  • News & Events
    • Press Releases
    • Events
    • Email Alerts
  • Investors
    • Overview
    • Press Releases
    • Events, Webcasts & Presentations
    • Financial Info
    • Stock Data
    • Filings
    • Governance
    • Contact Us
    • FAQ
  • Contact

Press Releases

News & Events

News & Events

  • Press Releases
  • Events
  • Email Alerts
Aug 06, 2012 8:05am EDT

Positive Clinical Trial Results for Immunovaccine's DPX-0907 Published in Journal of Translational Medicine

Jun 20, 2012 8:05am EDT

Immunovaccine's DPX-Survivac Featured in Presentation at Federation of Clinical Immunology Societies Conference (FOCIS 2012)

Jun 13, 2012 8:05am EDT

Immunovaccine to Present at Three Conferences in June

Jun 04, 2012 9:00am EDT

Immunovaccine's DPX-0907 Demonstrates Ability to Generate Promising Immune Reponses in Multiple Cancers in a Clinical Trial Presented at ASCO Annual Meeting

May 29, 2012 8:30am EDT

Immunovaccine to Present Clinical Data on its DPX-0907 Cancer Vaccine at the 2012 ASCO Annual Meeting

May 28, 2012 5:05pm EDT

Immunovaccine Announces Results of 2012 Annual General Meeting

May 24, 2012 4:05pm EDT

Immunovaccine Announces Financial Results for the Quarter Ended March 31, 2012

May 22, 2012 8:05am EDT

Immunovaccine to Host Annual General Meeting

May 10, 2012 8:05am EDT

Immunovaccine Signs Collaboration to Develop Sustained-Acting, Single Dose Vaccines for Pets

Apr 24, 2012 8:13am EDT

Immunovaccine Inc.: Biotech Investment Banker Leouzon to Join IMV Board

RSS
  • Prev
  • 1...
  • 28
  • 29
  • 30
  • 31
  • 32
  • 33
  • 34
  • 35
  • 36
  • 37
  • ...40
  • Next
IMV Inc.
About Us Careers The DPX™ Platform Clinical Pipeline News & Events Investors Contact
Twitter LinkedIn Youtube
© 2022 IMV Inc. All Rights Reserved.
Privacy Policy Disclaimer Sitemap